Zhou, Y.; Liao, M.; Li, Z.; Ye, J.; Wu, L.; Mou, Y.; Fu, L.; Zhen, Y.
Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer. Int. J. Mol. Sci. 2023, 24, 15121.
https://doi.org/10.3390/ijms242015121
AMA Style
Zhou Y, Liao M, Li Z, Ye J, Wu L, Mou Y, Fu L, Zhen Y.
Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer. International Journal of Molecular Sciences. 2023; 24(20):15121.
https://doi.org/10.3390/ijms242015121
Chicago/Turabian Style
Zhou, Yuxin, Minru Liao, Zixiang Li, Jing Ye, Lifeng Wu, Yi Mou, Leilei Fu, and Yongqi Zhen.
2023. "Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer" International Journal of Molecular Sciences 24, no. 20: 15121.
https://doi.org/10.3390/ijms242015121
APA Style
Zhou, Y., Liao, M., Li, Z., Ye, J., Wu, L., Mou, Y., Fu, L., & Zhen, Y.
(2023). Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer. International Journal of Molecular Sciences, 24(20), 15121.
https://doi.org/10.3390/ijms242015121